Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07202663) titled 'Study of BB-025, Alone and After BB-031, in Healthy Volunteers' on Sept. 24.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Basking Biosciences, Inc.
Condition:
Pharmacodynamics
Pharmacokinetics
Healthy Volunteers
Intervention:
Drug: BB-025
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: December 2025
Target Sample Size: 72
Countries of Recruitment:
Australia
To know more, visit https://clin...